ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

HCFA Disregards Pleas From Centers, ACCC, Sen. Dole, NCAB, AACI; Final DRG Regulations Made Even Tougher

January 13, 1984

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

July 4, 2014

BSA, BSC Approve Concept for NCI Scholars Program

March 7, 1997

Seven Divisions Proposed, Separating Intramural, Extramural Programs

August 11, 1995

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998